Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.

著者: Müller, F, Stiegler, C, Hadding, U
出版事項 1992

Establishment of T-helper type 1- and T-helper type 2-like human Toxoplasma antigen-specific T-cell clones.

著者: Däubener, W, Mackenzie, C, Hadding, U
出版事項 1995

The ninth component of human complement: isolation, description and mode of action

著者: Hadding, U., Müller-Eberhard, H. J.
出版事項 1969

An in vitro system to study listericidal capacity of macrophages from separate mice: resident macrophages exhibit different activation patterns.

著者: Ottendorfer, D, Bitter-Suermann, D, Hadding, U
出版事項 1985

Cytoadhesins of Mycoplasma hominis.

著者: Henrich, B, Feldmann, R C, Hadding, U
出版事項 1993

Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.

著者: Hamuro, J, Hadding, U, Bitter-Suermann, D
出版事項 1978

Studies on C3 convertases. Inhibition of C5 convertase formation by peptides containing aromatic amino acids.

著者: Kossorotow, A, Opitz, W, Etschenberg, E, Hadding, U
出版事項 1977

Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease.

著者: Böttger, E C, Hoffmann, T, Hadding, U, Bitter-Suermann, D
出版事項 1986

Bypass-activation of the complement system starting with C3: I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom

著者: Bitter-Suermann, D., Dierich, M., König, W., Hadding, U.
出版事項 1972

Insoluble polyanions as activators of both pathways of complement

著者: Burger, R., Bitter-Suermann, D., Loos, M., Hadding, U.
出版事項 1977

Decreased metabolism and viability of Mycoplasma hominis induced by monoclonal antibody-mediated agglutination.

著者: Feldmann, R C, Henrich, B, Kolb-Bachofen, V, Hadding, U
出版事項 1992

Clostridium difficile toxins A and B inhibit human immune response in vitro.

著者: Däubener, W, Leiser, E, von Eichel-Streiber, C, Hadding, U
出版事項 1988

Release of prostaglandin E and thromboxane from macrophages by stimulation with factor H.

著者: Hartung, H P, Hadding, U, Bitter-Suermann, D, Gemsa, D
出版事項 1984

Repetitive elements of the Mycoplasma hominis adhesin p50 can be differentiated by monoclonal antibodies.

著者: Henrich, B, Kitzerow, A, Feldmann, R C, Schaal, H, Hadding, U
出版事項 1996

Dextran sulphate: a synthetic activator of C3 via the alternative pathway. I. Influence of molecular size and degree of sulphation on the activation potency.

著者: Burger, R, Hadding, U, Schorlemmer, H U, Brade, V, Bitter-Suermann, D
出版事項 1975

Septicemia due toStreptococcus mitis in neutropenic patients with acute leukemia

著者: Arning, M., Gehrt, A., Aul, C., Runde, V., Hadding, U., Schneider, W.
出版年 Blut (1990)

Cell surface antigens on the guinea-pig macrophage: identification by monoclonal antibodies and association with the activation state.

著者: Mauer-Gross, U, von Steldern, D, Hadding, U, Bitter-Suermann, D, Burger, R
出版事項 1985

Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B.

著者: Flegel, W A, Müller, F, Däubener, W, Fischer, H G, Hadding, U, Northoff, H
出版事項 1991

Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency

著者: Dierich, M. P., Bitter-Suermann, D., König, W., Hadding, U., Galanos, C., Rietschel, E. T.
出版事項 1973

In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.

著者: Hoffmann, T, Böttger, E C, Baum, H P, Messner, M, Hadding, U, Bitter-Suermann, D
出版事項 1988